1039P Analysis of predictive and prognostic soluble biomarkers in advanced non-small cell lung cancer (NSCLC) patients treated with anti-PD1/PDL1

Autor:	S. Torres Martinez, M. Ferrero Gimeno, Carlos Camps, J. García Sánchez, R. Gisbert Criado, F.D.A. Aparisi Aparisi, J. Vidal Martínez, I. Shaheen, B. Honrubia Peris, A. Blasco Cordellat, J. Garde Noguera, E. Escorihuela, Ambar Moreno, S. Gallach Garcia, Silvia Calabuig-Fariñas, E. Jantus Lewintre, M. Meri Abad
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine Medicine non-small cell lung cancer (NSCLC) Hematology business medicine.disease Anti pd1
Zdroj:	Annals of Oncology. 31:S714
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.1159
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::cdf516d1e12a082d640af8c9f25617c8 https://doi.org/10.1016/j.annonc.2020.08.1159 Zobrazit plný text záznamu